X0306 4 2021-06-15 0 0001595893 Turning Point Therapeutics, Inc. TPTX 0001341011 North Annette C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO CA 92121 0 1 0 0 EVP, General Counsel & Secty. Common Stock 2021-06-15 4 M 0 15000 17.00 A 27365 D Common Stock 2021-06-15 4 S 0 5666 75.94 D 21699 D Common Stock 2021-06-15 4 S 0 2700 77.37 D 18999 D Common Stock 2021-06-15 4 S 0 6634 77.82 D 12365 D Stock Option (right to buy) 17.00 2021-06-15 4 M 0 15000 0.00 D 2029-04-14 Common Stock 15000 154609 D Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020. The weighted average sale price for the transaction reported was $75.94, and the range of prices were between $75.49 and $76.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $77.37, and the range of prices were between $76.575 and $77.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $77.82, and the range of prices were between $77.59 and $78.21. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested. /s/ Annette North 2021-06-16